Head-to-head · WeighScore
Liberty vs Nurx
The verdict
Nurx takes it — 66.5/100 to 61/100.
Nurx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established women's telehealth brand offering tiered GLP-1 weight loss programs.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Liberty | Nurx |
|---|---|---|
| WeighScore | 61/100 | 66.5/100 |
| Grade | C | C |
| Scorecard rank | #304 | #185 |
| Semaglutide | $199/mo (compounded) | $179/mo (starting dose, compounded) |
| Tirzepatide | $299/mo (compounded) | $179/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #304 · C
Strengths
- Compounded GLP-1 sourced from FDA-registered 503B outsourcing facilities, a stricter standard than the 503A pharmacies many competitors use
- Transparent flat pricing: compounded semaglutide $199/mo (about $171/mo on a 3-month supply) and tirzepatide $299/mo
- Nationwide in all 50 states with free discreet shipping, 24/7 support, and FSA/HSA acceptance
- Multi-vertical menu beyond weight loss (low-dose microdosing, NAD+, sermorelin, metformin) for patients who want bundled wellness care
Where it loses points
- Does not name its specific compounding pharmacy partner, only that it is a 503B facility
- Tirzepatide at $299/mo is mid-market rather than the cheapest option among compounded providers
- Generic corporate branding (Liberty Health) with limited public detail on the operating entity
- Compounded medication only — no brand-name or insurance-covered GLP-1 path
Graded #185 · C
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- Limited public information on program details
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.